Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
Completed · Phase 2
Conditions studied: Hepatitis C Virus Infection
In brief
The purpose of this study is to provide anti-hepatitis C virus drugs to patients who received placebo + peginterferon alfa-2a + ribavirin in prior Bristol-Myers Squibb (BMS) studies and determine whether addition of these drugs results in higher cure rates in patients who previously failed therapy. Approximately 100 genotype 1b patients who received placebo in BMS study NCT01428063 (AI447-028) will receive active drugs in this study.
Key facts
- Study ID
- NCT01428063
- Run by
- Bristol-Myers Squibb
- People needed
- 276
- Starts
- 2011-09-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2016-05-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Scripps Clinic — La Jolla, California, United States
- Scpmg/ Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States
- University Of Colorado Denver And Hospital — Aurora, Colorado, United States
- Yale University School Of Medicine — New Haven, Connecticut, United States
- Uf Hepatology Research At Ctrb — Gainesville, Florida, United States
- Schiff Center For Liver Diseases — Miami, Florida, United States
- Mercy Medical Center — Baltimore, Maryland, United States
- Digestive Disease Associates, P.A. — Catonsville, Maryland, United States
- Henry Ford Health System — Detroit, Michigan, United States
- Washington University School Of Medicine — St Louis, Missouri, United States
- North Shore Long Island Jewish Health System — Manhasset, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Options Health Research, Llc — Tulsa, Oklahoma, United States
- University Of Pennsylvania — Philadelphia, Pennsylvania, United States
- Nashville Medical Research Institute — Nashville, Tennessee, United States
- Baylor College Of Medicine — Houston, Texas, United States
- Alamo Medical Research — San Antonio, Texas, United States
- Metropolitan Research — Fairfax, Virginia, United States
- Dean Clinic — Madison, Wisconsin, United States
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Ciudad de Buenos Aires, Buenos Aires, Argentina
- Local Institution — Ciudad de Buenos Aires, Buenos Aires, Argentina
- Local Institution — Prov. Buenos Aires, Buenos Aires, Argentina
- Local Institution — Prov de Santa Fe, Santa Fe Province, Argentina
- Baptist Medical Center South — Montgomery, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.